Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort Turbuhaler with or without theophylline for COPD
ChiCTR-TRC-10000969Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- May 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of budesonide and theophylline in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Frequency of acute exacerbation of chronic obstructive pulmonary disease and Mortality rate. Started May 2010; status: completed.
02
Drugs
budesonidetheophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-10000969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000969.